Intrinsic Value of S&P & Nasdaq Contact Us

ACADIA Pharmaceuticals Inc. ACAD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
85/100
5/7 Pass
SharesGrow Intrinsic Value
$24.35
+10.6%
Analyst Price Target
$34.78
+57.9%

ACADIA Pharmaceuticals Inc. (ACAD) has 20 known insider and institutional holders on record. The largest holder is Baker Brothers Life Sciences LP with 38,469,981 shares. Other notable holders include 14159, L.P. and Adams Catherine Owen.

Over the last 12 months, insiders have made 45 transactions in ACAD stock — 12 buys (valued at $614.89K) and 17 sells (valued at $2.73M). Insider selling has exceeded buying during this period.

ACAD Insider Ownership

Top Holder
Baker Brothers Life Sciences LP
38,469,981 shares
Buys (12 mo)
12
$614.89K value
Sells (12 mo)
17
$2.73M value
12-Month Transaction Activity
Buy 27%
Sell 38%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Baker Brothers Life Sciences Lp Director 38,469,981 2022-06-09
100%
2 14159, L.p. 10 Percent Owner 2,337,100 2016-01-08
6%
3 Adams Catherine Owen Chief Executive Officer 353,261 2024-09-25
1%
4 Davis Stephen CEO 173,520 2024-08-20
0%
5 Stankovic Srdjan R. President 63,081 2022-11-22
0%
6 Williamson Douglas J Executive VP, Research & Dev 50,655 2023-02-13
0%
7 Kim Austin D. EVP,general Counsel, Secretary 46,901 2024-01-09
0%
8 Moore Terrence O EVP, Chief Commercial Officer 33,750 2017-03-10
0%
9 Garner Thomas EVP, Chief Commercial Officer 28,493 2026-03-10
0%
10 Baity Glenn EVP and Gc 28,125 2018-04-20
0%
11 Baker Bros. Advisors Lp 10 Percent Owner 27,586 2025-06-02
0%
12 Owen Adams Catherine Chief Executive Officer 26,444 2026-03-26
0%
13 Garofalo Elizabeth A. Director 25,382 2025-09-03
0%
14 Schneyer Mark C. EVP, Chief Financial Officer 24,414 2026-03-26
0%
15 Rhodes Jennifer J EVP, Chief Legal Officer, Sec 15,124 2026-03-26
0%
16 Brege Laura Director 15,095 2025-06-05
0%
17 Soland Daniel B Director 13,059 2023-06-05
0%
18 Teehan Brendan EVP, COO, Head of Commercial 9,913 2024-11-19
0%
19 Yang Michael J. EVP and Cco 8,059 2021-01-08
0%
20 Thompson Elizabeth H.z. EVP, Head of Research & Dev 6,715 2026-03-26
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-26 Schneyer Mark C. EVP, Chief Financial Officer Informative Sell 37 $21.72 $803.54
2026-03-25 Schneyer Mark C. EVP, Chief Financial Officer Option Exercise (Sell) 6,178 - -
2026-03-24 Schneyer Mark C. EVP, Chief Financial Officer Option Exercise (Sell) 8,138 - -
2026-03-25 Thompson Elizabeth H.z. EVP, Head of Research & Dev Informative Sell 3,435 $21.47 $73.75K
2026-03-24 Thompson Elizabeth H.z. EVP, Head of Research & Dev Option Exercise 6,715 - -
2026-03-25 Owen Adams Catherine Chief Executive Officer Informative Sell 11,641 $21.47 $249.93K
2026-03-24 Owen Adams Catherine Chief Executive Officer Option Exercise 23,509 - -
2026-03-26 Kihara James Principal Accounting Officer Informative Sell 12 $21.73 $260.70
2026-03-25 Kihara James Principal Accounting Officer Option Exercise (Sell) 2,142 - -
2026-03-24 Kihara James Principal Accounting Officer Option Exercise (Sell) 1,627 - -
2026-03-25 Rhodes Jennifer J EVP, Chief Legal Officer, Sec Informative Sell 3,844 $21.47 $82.53K
2026-03-24 Rhodes Jennifer J EVP, Chief Legal Officer, Sec Option Exercise 7,515 - -
2026-03-03 Poole Jonathan Director RSU Award 2,010 - -
2026-03-03 Poole Jonathan Officer Unknown - - -
2026-03-06 Garner Thomas EVP, Chief Commercial Officer RSU Award 28,493 - -
2026-03-06 Schneyer Mark C. EVP, Chief Financial Officer RSU Award 26,382 - -
2026-03-06 Thompson Elizabeth H.z. EVP, Head of Research & Dev RSU Award 29,548 - -
2026-03-06 Owen Adams Catherine Chief Executive Officer RSU Award 76,509 - -
2026-03-06 Kihara James Principal Accounting Officer RSU Award 6,332 - -
2026-03-06 Rhodes Jennifer J EVP, Chief Legal Officer, Sec RSU Award 26,382 - -
2026-02-09 Rhodes Jennifer J EVP, Chief Legal Officer, Sec Informative Sell 6,950 $23.38 $162.49K
2026-02-06 Rhodes Jennifer J EVP, Chief Legal Officer, Sec Option Exercise (Sell) 12,944 - -
2025-11-18 Schneyer Mark C. EVP, Chief Financial Officer Informative Sell 10,262 $23.69 $243.11K
2025-11-17 Schneyer Mark C. EVP, Chief Financial Officer Option Exercise (Sell) 9,913 - -
2025-11-18 Kihara James Principal Accounting Officer Informative Sell 4,084 $23.69 $96.75K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message